国泰君安创新医药混合发起A(014157)资产配置
| 序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
| 1 |
2024-12-31 |
68.22 |
- |
33.67 |
232,028,963.87 |
| 2 |
2024-09-30 |
86.86 |
- |
13.27 |
130,461,525.38 |
| 3 |
2024-06-30 |
82.47 |
- |
17.72 |
106,310,898.58 |
| 4 |
2024-03-31 |
85.64 |
- |
14.59 |
107,092,845.03 |
| 5 |
2023-12-31 |
83.47 |
- |
16.78 |
118,915,556.88 |
| 6 |
2023-09-30 |
87.12 |
- |
13.03 |
123,360,061.33 |
| 7 |
2023-06-30 |
84.04 |
- |
16.27 |
117,795,375.84 |
| 8 |
2023-03-31 |
79.07 |
- |
24.25 |
189,374,180.17 |
| 9 |
2022-12-31 |
77.47 |
- |
22.77 |
33,252,752.70 |
| 10 |
2022-09-30 |
79.28 |
- |
20.95 |
28,757,096.64 |
| 11 |
2022-06-30 |
78.68 |
- |
21.52 |
31,291,109.60 |
| 12 |
2022-03-31 |
79.44 |
- |
20.82 |
30,983,895.64 |
微信公众号
证券之星APP
基本资料
